Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Oak Associates

LOGSX Holdings: What Live Oak Health Sciences Fund Owns

Ticker LOGSX · · Holdings as of Jul 31, 2026

Expense ratio
1.04%$104/yr per $10k
5-yr return
+8.1%annualized
1-yr return
+19.6%as of Dec 2025
Net assets
$56.1Mall share classes
Holdings
28

Bottom line

What does LOGSX hold?

LOGSX held 28 positions as of Jul 31, 2026. Its largest holding is N/a at 6.91% of the fund, and the top 10 positions add up to 51.8%. By asset type it is 97% stocks, 7% repurchase agreements, 2% cash & short-term funds.

Updated Sep 29, 2026

LOGSX top 25 holdings

#HoldingType% of fundValue
1 N/a
Prime Solutions 3.25% 8/3/26
Repurchase agreements 6.91%$3.9M
2 Cardinal Health Inc
Cardinal Health, Inc.
Stocks 5.86%$3.3M
3 Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals plc
Stocks 5.77%$3.2M
4 United Therapeutics Corp
United Therapeutics Corporation
Stocks 5.11%$2.9M
5 Exelixis Inc
Exelixis, Inc.
Stocks 4.95%$2.8M
6 Amgen Inc
Amgen, Inc.
Stocks 4.86%$2.7M
7 Lantheus Holdings Inc
Lantheus Holdings, Inc.
Stocks 4.68%$2.6M
8 Novartis Ag
Novartis A.G.
Stocks 4.67%$2.6M
9 Mckesson Corp
McKesson Corporation
Stocks 4.53%$2.5M
10 Cencora Inc
Cencora, Inc.
Stocks 4.46%$2.5M
11 Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals, Inc.
Stocks 4.43%$2.5M
12 Bristol-myers Squibb Company
Bristol-Myers Squibb Company
Stocks 4.02%$2.3M
13 National Healthcare Corp
National HealthCare Corporation
Stocks 3.87%$2.2M
14 Johnson & Johnson
Johnson & Johnson
Stocks 3.77%$2.1M
15 Medpace Holdings Inc
Medpace Holdings, Inc.
Stocks 3.69%$2.1M
16 Gilead Sciences Inc
Gilead Sciences, Inc.
Stocks 3.50%$2.0M
17 Cigna Group (the)
Cigna Group (The)
Stocks 3.46%$1.9M
18 Incyte Corp
Incyte Corporation
Stocks 3.30%$1.9M
19 Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals, Inc.
Stocks 3.26%$1.8M
20 Merck & Company Inc
Merck & Company, Inc.
Stocks 3.16%$1.8M
21 Medtronic Plc
Medtronic plc
Stocks 3.01%$1.7M
22 Intuitive Surgical Inc
Intuitive Surgical, Inc.
Stocks 2.99%$1.7M
23 Novo Nordisk A/s
Novo Nordisk A/S
Stocks 2.51%$1.4M
24 Labcorp Holdings Inc
Labcorp Holdings, Inc.
Stocks 2.29%$1.3M
25 Eli Lilly & Company
Eli Lilly & Company
Stocks 1.99%$1.1M

Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 29, 2026

Asset mix

Stocks97.2%
Repurchase agreements6.9%
Cash & short-term funds1.6%

Country exposure

CH4.7%
DK2.5%
IE8.8%
US89.7%